| Table 2: Summary of rabbit immunogenicity studies with different EV71 vaccine candidates. |
| | EV71 vaccine candidates | Adjuvant formulated | Total IgG titers | Western blot | Virus neutralization titer | | VP1-43 | VP2-28 | rVP1 | rVP2 | rVP3 | EV71 (B4 E59) | CVA16 (N5079) |
| | 2 μg of inactivated | | | | | | | | | | EV71 virion | PBS | 1/200 | 1/800 | +++ | +++ | ++ | 1/128 | <1/8 | | EV71 virion | Alum | 1/200 | 1/6400 | +++ | +++ | ++ | 1/6400 | 1/32 |
| | 5 μg of inactivated | | | | | | | | | | EV71 virion | Alum | 1/200 | 1/6400 | +++ | +++ | +++ | 1/12800 | 1/64 |
|
|
Two to three rabbits per group were immunized 3 times with EV71 vaccine candidates alone or formulated with alum. The protocols for IgG titer determination, western blot analysis, and virus neutralization assay are described in Section 2.
|